Evonik expands R&D center in Shanghai, China
• Evonik has invested close to €23 million in the third expansion of its R&D Center in Shanghai, with a footprint of more than 14,000 square meters
• The aim is to develop product applications and providing technology service for customers in Asia
• The new R&D building is the first LEED certified building for Evonik worldwide
China/Shanghai. Following a construction period of two years, Evonik Industries has unveiled its new Research & Development (R&D) center in Shanghai Xinzhuang. With the successful completion, Evonik has expanded its R&D center in Shanghai for third times since its establishment in 2004. A total investment of €23 million, the new five-storey R&D building covers an area of more than 14,000 square meters, housing 50 standard labs, conference facilities and a show room demonstrating Evonik’s diversified products and solutions. The new R&D building is also the first LEED* (Leadership in Energy & Environmental Design) certified building for Evonik worldwide.
“In order to strengthen our position as a global leading specialty chemicals company, Evonik places so much emphasis on innovation, particularly in China. Ultimately, our goal is to offer our customers tailored solutions for their own markets and specific needs,” said Patrik Wohlhauser, member of the Executive Board of Evonik Industries AG, at the opening ceremony.
High innovative capability is vital for Evonik as a world leader in specialty chemicals. It drives profitable growth and strengthens our position as a market and technology leader. Alongside our applications technology laboratories at several sites, the R&D center in Shanghai-Xinzhuang plays a key role in Evonik’s global R&D strategy. “Creating innovative products and solutions that satisfy changing customer needs is at the core of our business. With the expansion, we are strengthening the local R&D capacity by expanding our activities from technical service to product development,” said Dr. Hans-Josef Ritzert, President Evonik Greater China region. After the expansion, the Shanghai R&D Center has a total of 35,000 square meters of space, developing product applications and providing technology services for customers in Asia.
In addition, a wide variety of Evonik products are applied in the new R&D building, ranging from external wall, roof, and toilets to interior decoration. The approach is to make the new R&D building a concrete example for our customers and visitors of how Evonik products and solutions can be put into specific use. For example, the show room on the ground floor of the new R&D building is packing plenty of PLEXIGLAS® products – acrylic polymer sheets, ranging from wall, product display compartment, signage to lightings.
Evonik has been stepping up R&D in the Asian growth markets for years, aiming to help strengthen the competitiveness of our Asian customers through research and applications technology geared specifically to local needs. For example, with the establishment of Science to Business Center (S2B) Bio and analytic center AQura in the new R&D building, Evonik endeavors to strengthen its basic research competency in the region. S2B Bio is responsible for the evaluation of technologies, research cooperation with Chinese partners, technology scale-up and commercialization for the Chinese market. AQura is the Evonik competence center for chemical, physicochemical analysis and safety testing.
* LEED is a suite of rating systems for green buildings developed by the U.S. Green Building Council.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world. In fiscal 2012 more than 33,000 employees generated sales of around €13.4 billion and an operating profit (adjusted EBITDA) of about €2.4 billion.
Evonik Industries has been producing specialty chemical products in the Greater China region (Mainland China, Hong Kong and Taiwan) since the late1970’s; with wide-ranging trading relations already in place prior to this in the region. Evonik regards Greater China as one of the driving forces of the global economy and we consequently endeavour to grow our business in the region. The company now has around 3,500 employees in the Greater China region, the regional sales reached over 1 billion in 2012.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.